REQUEST A DEMO
Total
USD $0.00
Search more companies

Dolvis Bio Pharma Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Dolvis Bio Pharma Private Limited Profile Updated: May 20, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Dolvis Bio Pharma Private Limited is an unlisted company, incorporated on 27/03/2012. It has its registered office in the State of Chandigarh, India. Company's corporate identification number (CIN) is U24232CH2012PTC033674 and registration number is 033674. The company is a trade company, it is engaged in wholesale trading.

Legal Address
Scf 265, Second Floor Motor Market
Chandigarh; Punjab; Postal Code: 160101

Contact Details: Purchase the Dolvis Bio Pharma Private Limited report to view the information.

Basic Information
Outstanding Shares:
Purchase the Dolvis Bio Pharma Private Limited report to view the information.
Registered Capital:
Purchase the Dolvis Bio Pharma Private Limited report to view the information.
Incorporation Date:
March 27, 2012
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Company Performance
Financial values in the chart are available after Dolvis Bio Pharma Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
0.62%
Total operating revenue
1.33%
Operating profit (EBIT)
-3.97%
EBITDA
2.88%
Net Profit (Loss) for the Period
-1.66%
Total assets
4.09%
Total equity
24.67%
Operating Profit Margin (ROS)
-0.18%
Net Profit Margin
-0.07%
Return on Equity (ROE)
-5.57%
Debt to Equity Ratio
-22.14%
Quick Ratio
0.1%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?